You are here

Clarus Therapeutics

Clarus picks up FDA OK for oral testosterone drug

BioPharma Dive

Sat, 03/30/19 - 12:05 am

Clarus Therapeutics

The FDA still hates low T drugs — experts bat back a pair of contenders

Endpoints

Thu, 01/11/18 - 09:46 am

Clarus Therapeutics

FDA advisers shoot down Clarus' pitch for a new low-T drug

Fierce Biotech

Fri, 09/19/14 - 08:58 am

Clarus Therapeutics

advisory panels

Possible Heart Risk With Testosterone Spurs Debate on Use

Bloomberg

Tue, 09/16/14 - 09:24 am

Clarus Therapeutics

Clarus Therapeutics Files To Sell Up To $86.3M In Shares In IPO

WSJ

Sat, 11/20/10 - 12:47 pm

Clarus Therapeutics